Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.

Literature DB >> 10851379

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.

H Openshaw¹, O Stuve, J P Antel, R Nash, B T Lund, L P Weiner, A Kashyap, P McSweeney, S Forman.

Abstract

Four of 10 patients who were enrolled on protocols of high-dose immunosuppression with peripheral blood stem cell rescue for MS experienced neurologic worsening while receiving recombinant human granulocyte colony-stimulating factor. There was improvement when methylprednisolone was given to three of the patients, but one patient died of respiratory failure. The mechanism of the neurologic worsening is uncertain.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2000 PMID： 10851379 DOI： 10.1212/wnl.54.11.2147

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

49 in total

1. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

Authors: Peter A McSweeney; Richard A Nash; Keith M Sullivan; Jan Storek; Leslie J Crofford; Roger Dansey; Maureen D Mayes; Kevin T McDonagh; J Lee Nelson; Theodore A Gooley; Leona A Holmberg; C S Chen; Mark H Wener; Katherine Ryan; Julie Sunderhaus; Ken Russell; John Rambharose; Rainer Storb; Daniel E Furst
Journal: Blood Date: 2002-09-01 Impact factor: 22.113

2. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Authors: D Farge; J Passweg; J M van Laar; Z Marjanovic; C Besenthal; J Finke; H H Peter; F C Breedveld; W E Fibbe; C Black; C Denton; I Koetter; F Locatelli; A Martini; A V N Schattenberg; F van den Hoogen; L van de Putte; F Lanza; R Arnold; P A Bacon; S Bingham; F Ciceri; B Didier; J L Diez-Martin; P Emery; W Feremans; B Hertenstein; F Hiepe; R Luosujärvi; A Leon Lara; A Marmont; A M Martinez; H Pascual Cascon; C Bocelli-Tyndall; E Gluckman; A Gratwohl; A Tyndall
Journal: Ann Rheum Dis Date: 2004-08 Impact factor: 19.103

Review 3. Innate immunity in the central nervous system.

Authors: Richard M Ransohoff; Melissa A Brown
Journal: J Clin Invest Date: 2012-04-02 Impact factor: 14.808

4. Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors: Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal: JCI Insight Date: 2019-04-02

5. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.

Authors: S Bräuninger; K Thorausch; B Luxembourg; M Schulz; K U Chow; E Seifried; H Bonig
Journal: Bone Marrow Transplant Date: 2014-08-04 Impact factor: 5.483

6. Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient.

Authors: Mariano Marrodan; Julia Laviano; Sofía Oneto; Fabricio M Reino; Ricardo Delorme; Florencia Fornillo; José Férnandez; Jorge Correale
Journal: Neurol Sci Date: 2021-06-01 Impact factor: 3.307

Review 7. Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis.

Authors: Harold L Atkins; Mark S Freedman
Journal: Neurotherapeutics Date: 2017-10 Impact factor: 7.620